BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12563025)

  • 1. Leptin administration normalizes insulin secretion from islets of Lep(ob)/Lep(ob) mice by food intake-dependent and -independent mechanisms.
    Lee JW; Romsos DR
    Exp Biol Med (Maywood); 2003 Feb; 228(2):183-7. PubMed ID: 12563025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin constrains phospholipase C-protein kinase C-induced insulin secretion via a phosphatidylinositol 3-kinase-dependent pathway.
    Lee JW; Swick AG; Romsos DR
    Exp Biol Med (Maywood); 2003 Feb; 228(2):175-82. PubMed ID: 12563024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin-deficient mice commence hypersecreting insulin in response to acetylcholine between 1 and 2 weeks of age.
    Lee JW; Romsos DR
    Exp Biol Med (Maywood); 2001 Nov; 226(10):906-11. PubMed ID: 11682696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone-sensitive lipase deficiency suppresses insulin secretion from pancreatic islets of Lep ob/ob mice.
    Sekiya M; Yahagi N; Tamura Y; Okazaki H; Igarashi M; Ohta K; Takanashi M; Kumagai M; Takase S; Nishi M; Takeuchi Y; Izumida Y; Kubota M; Ohashi K; Iizuka Y; Yagyu H; Gotoda T; Nagai R; Shimano H; Yamada N; Kadowaki T; Ishibashi S; Osuga J
    Biochem Biophys Res Commun; 2009 Sep; 387(3):511-5. PubMed ID: 19619509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin constrains acetylcholine-induced insulin secretion from pancreatic islets of ob/ob mice.
    Chen NG; Swick AG; Romsos DR
    J Clin Invest; 1997 Sep; 100(5):1174-9. PubMed ID: 9276734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-fat diet induces leptin resistance in leptin-deficient mice.
    Koch CE; Lowe C; Pretz D; Steger J; Williams LM; Tups A
    J Neuroendocrinol; 2014 Feb; 26(2):58-67. PubMed ID: 24382295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin acts peripherally to limit meal-induced increases in plasma insulin concentrations in mice: a brief communication.
    Mistry AM; Swick AG; Romsos DR
    Exp Biol Med (Maywood); 2004 Nov; 229(10):1033-7. PubMed ID: 15522839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
    Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
    Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenalectomy suppresses insulin secretion from pancreatic islets of ob/ob mice.
    Okuda T; Romsos DR
    Int J Obes Relat Metab Disord; 1994 Dec; 18(12):801-5. PubMed ID: 7894518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Threshold for glucose-stimulated insulin secretion in pancreatic islets of genetically obese (ob/ob) mice is abnormally low.
    Chen NG; Tassava TM; Romsos DR
    J Nutr; 1993 Sep; 123(9):1567-74. PubMed ID: 8360782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of leptin, acetylcholine and vasoactive intestinal polypeptide on insulin secretion in isolated ob/ob mouse pancreatic islets.
    Persson-Sjögren S; Elmi A; Lindström P
    Acta Diabetol; 2004 Sep; 41(3):104-12. PubMed ID: 15666577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in
    Shimazu-Kuwahara S; Harada N; Yamane S; Joo E; Sankoda A; Kieffer TJ; Inagaki N
    Mol Metab; 2017 Mar; 6(3):288-294. PubMed ID: 28271035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
    Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
    Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice.
    Flowers JB; Rabaglia ME; Schueler KL; Flowers MT; Lan H; Keller MP; Ntambi JM; Attie AD
    Diabetes; 2007 May; 56(5):1228-39. PubMed ID: 17369521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double leptin and melanocortin-4 receptor gene mutations have an additive effect on fat mass and are associated with reduced effects of leptin on weight loss and food intake.
    Trevaskis JL; Butler AA
    Endocrinology; 2005 Oct; 146(10):4257-65. PubMed ID: 15994342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumption of a glucose diet enhances the sensitivity of pancreatic islets from adrenalectomized genetically obese (ob/ob) mice to glucose-induced insulin secretion.
    Mistry AM; Chen NG; Lee YS; Romsos DR
    J Nutr; 1995 Mar; 125(3):503-11. PubMed ID: 7876925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurine supplementation ameliorates glucose homeostasis, prevents insulin and glucagon hypersecretion, and controls β, α, and δ-cell masses in genetic obese mice.
    Santos-Silva JC; Ribeiro RA; Vettorazzi JF; Irles E; Rickli S; Borck PC; Porciuncula PM; Quesada I; Nadal A; Boschero AC; Carneiro EM
    Amino Acids; 2015 Aug; 47(8):1533-48. PubMed ID: 25940922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term leptin treatment of ob/ob mice improves glucose-induced insulin secretion.
    Khan A; Narangoda S; Ahren B; Holm C; Sundler F; Efendic S
    Int J Obes Relat Metab Disord; 2001 Jun; 25(6):816-21. PubMed ID: 11439295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central leptin gene therapy corrects skeletal abnormalities in leptin-deficient ob/ob mice.
    Iwaniec UT; Boghossian S; Lapke PD; Turner RT; Kalra SP
    Peptides; 2007 May; 28(5):1012-9. PubMed ID: 17346852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of phosphatidylinositol 3-kinase amplify insulin release from islets of lean but not obese mice.
    Zawalich WS; Tesz GJ; Zawalich KC
    J Endocrinol; 2002 Aug; 174(2):247-58. PubMed ID: 12176663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.